#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ureteric cancer Alveolar proteinosis Anti-myelin-associated glycoprotein associated polyneuropathy Renal cancer metastatic Nasopharyngeal cancer Synovial sarcoma Polymyositis Prodromal Alzheimer's disease Familial hypertriglyceridaemia Kawasaki's disease Fibrodysplasia ossificans progressiva Malformation venous Astrocytoma malignant Usher's syndrome Anti-HLA antibody test positive More trials…

    Learn about Rare Diseases

    Pulmonary sarcoidosis Glycogen storage disease type V – Diagnostics Marginal zone lymphoma – Life with Disease Leiomyosarcoma metastatic Ocular melanoma – Life with Disease Gastrointestinal stromal tumour – Treatment Arterial tortuosity syndrome – Basic Information Pemphigoid – Life with Disease Chordoma Haemophilia B with anti factor IX – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Febuxostat Tropicamide Rizolipase Trametinib Dimethyl Sulfoxide Vusolimogene Oderparepvec Mitoxantrone Hydrochloride Tamoxifen Pasireotide Methoxsalen Sodium Iodide (123 I) Viltolarsen Vibostolimab Ly3484356 Icosapent Ethyl MEGESTROL ACETATE Ly3537982 Hydroxocobalamin Lenzumestrocel Apalutamide Emapalumab More therapies…

    Learn about Your Condition

    Lichen sclerosus Malignant neoplasm of choroid Retinal vein occlusion Inguinal hernia Anaemia of pregnancy Dry mouth Bipolar disorder Intestinal ischaemia Mental disorder Neuralgia Sciatica Cushing's syndrome Eructation Epicondylitis Erosive oesophagitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Osteo-Medic s.c. Artur Racewicz, Jerzy Supronik

Osteo-Medic s.c. Artur Racewicz, Jerzy Supronik

ul. Wiejska 81, Bialystok, 15-351, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of Tildrakizumab for Patients with Moderate to Severe Genital Psoriasis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Tildrakizumab
    Bulgaria Hungary Poland

  • Study on the Effectiveness and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab for Patients with Moderate to Severe Plaque Psoriasis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Jnj-77242113
    • Ustekinumab
    Austria Belgium Denmark Germany Hungary Poland +2

  • Study on the Effectiveness and Safety of JNJ-77242113 for Patients with Active Psoriatic Arthritis Who Have Not Used Biologic Treatments

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Jnj-77242113
    • Ustekinumab
    Bulgaria Czechia Denmark Germany Hungary Poland +1

  • Study Comparing CT-P55 and Secukinumab for Moderate to Severe Plaque Psoriasis Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Secukinumab
    Poland

  • Study on the Effectiveness and Safety of CT-P13 for Patients with Moderate to Severe Rheumatoid Arthritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Folic Acid
    • Hydrocortisone
    • HYDROXYCHLOROQUINE
    Poland

  • Study on Long-term Safety and Effectiveness of Zasocitinib for Patients with Moderate-to-Severe Plaque Psoriasis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Zasocitinib
    Bulgaria Czechia France Germany Hungary Italy +3

  • Study Comparing MAB-22 and Denosumab for Treating Osteoporosis in Postmenopausal Women

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteoporosis
    Investigated Drugs:
    • Denosumab
    Bulgaria Czechia Poland

  • Study of LY3556050 for Adults with Diabetic Peripheral Neuropathy Pain

    Not recruiting

    2 1
    Investigated Diseases:
    • Diabetic neuropathy
    Investigated Drugs:
    • Ly3556050
    Czechia Poland

  • Study on the Safety and Effectiveness of Upadacitinib for Adults and Adolescents with Severe Alopecia Areata

    Not recruiting

    3 1
    Investigated Diseases:
    • Alopecia areata
    Investigated Drugs:
    • Upadacitinib
    Belgium Bulgaria Croatia France Germany Greece +7

  • Study on the Effects of Upadacitinib in Adults and Adolescents with Non-Segmental Vitiligo Eligible for Systemic Treatment

    Not recruiting

    3 1
    Investigated Diseases:
    • Vitiligo
    Investigated Drugs:
    • Upadacitinib
    Belgium Bulgaria France Germany Hungary Italy +5
Previous Page
1 2 3 4 5
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!